MRD-guided Deferred Adjuvant Therapy in Resectable Early-stage Colon Cancer — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

MRD-guided Deferred Adjuvant Therapy in Resectable Early-stage Colon Cancer — Stella

Recruiting

Back to Colorectal Cancer trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

China

Sun Yat-sen University Cancer Center, Guangzhou, Guangdong

Key details

Sponsor

Sun Yat-sen University

Collaborators

Guangzhou Burning Rock Dx Co., Ltd.

Enrollment target

~349 participants

Started

July 2023

Primary completion

July 2028

Age range

18 Years – 70 Years

Last updated January 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov